Loading
Life sciences · Journal article
Heliyon · September 1, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review of microfluidic technology and its potential applications in wound healing and skin disease diagnosis and treatment. The source describes technological capabilities and highlights an underexplored area but does not report original clinical trial data, comparative efficacy, or outcome evidence.
Journal article.
Microfluidic devices can substantially reduce diagnostic turnaround time for skin infections compared with conventional culture-based methods. Microfluidics enables real-time monitoring of wound biomarkers including IL-6 and TNF-α. Technology allows reduced reagent consumption, faster processing, and high-throughput analysis.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a narrative review summarizing potential applications of microfluidic technology in wound healing and skin disease; it raises questions and describes emerging capabilities rather than reporting a primary clinical trial or definitive evidence.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Microfluidics enables the precise manipulation of fluids and bioparticles at the micro-to nanoscale using miniaturized architectures. This technology offers distinct advantages compared to conventional assays, including reduced reagent consumption, faster processing that can save hours, and high-throughput analysis, making it valuable in biomedical applications. Microfluidic devices can substantially reduce the diagnostic turnaround time for skin infections compared with conventional culture-based methods. Lately, microfluidics has emerged as a versatile platform to fabricate functional materials, targeted drug delivery systems, lab-on-a-chip and organ-on-a-chip devices, and cellular analyzers. These technologies improve transdermal drug delivery efficiency and facilitate real-time monitoring of wound biomarkers such as IL-6 and TNF-α. Unlike oncology or infectious disease diagnostics, microfluidics in wound care and skin disease management remains underexplored. This review underscores recent advancements in microfluidic systems for wound healing to deliver antimicrobials, stimulate angiogenesis, and guide tissue regeneration. Furthermore, it also highlights diagnostic microfluidics-enabled platforms for skin disease diagnosis and personalized therapy through dynamic feedback systems. The study delineates the potential of integrating microfluidics into next-generation regenerative medicine.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.